Minaprine

This classification denotes an antidepressant agent with the molecular formula C17H22N4O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 00U7GX0NLM, chemically known as 4-morpholineethanamine, n- (4-methyl-6-phenyl-3-pyridazinyl)-, dihydrochloride but generally known as minaprine, which bears US NIH Compound Identifier 4199. European Medicines Agency schedules Minaprine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08974MIG. The term MINAPRINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). World Health Organization schedules minaprine in its Anatomical Therapeutic Chemical (ATC) Classification. MINAPRINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule minaprine under HS 29349990 and SITC 51579. As of Q4 2014, MINAPRINE remains the US FDA Preferred Term for this commodity. Minaprine bears US NLM identifiers UMLS ID C0066561 and NCI Concept Code C66158. SMILES: O1CCN(CC1)CCNc1nnc(cc1C)c1ccccc1.